NLNa-Lin Lai

Na-Lin Lai

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Na-Lin Lai has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Chong Gao

    Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, USA

    2 shared publications
  • Xiao-Feng Li

    Department of Rheumatology and Immunology, Second Hospital of Shanxi Medical University, Shanxi Key Laboratory of Rheumatism Immune Microecology, Shanxi Precision Medical Engineering Research Center for Rheumatology, Taiyuan, Shanxi, China.

    2 shared publications
  • Caihong Wang

    Department of Rheumatology, The Second Hospital of Shanxi Medical University, Taiyuan, China

    1 shared publication
  • Guang-Ying Liu

    Department of Rheumatology, The Second Hospital of Shanxi Medical University, 382 Wuyi Road, Taiyuan, Shanxi 030001, China

    1 shared publication
  • Jia Wang

    Department of Rheumatology, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China

    1 shared publication
  • Jia-Qian Zhang

    Department of Rheumatology, The Second Hospital of Shanxi Medical University, 382 Wuyi Road, Taiyuan, Shanxi 030001, China

    1 shared publication

Latest Publications

  • Open Access

    Risk Factors and Changes of Peripheral NK and T Cells in Pulmonary Interstitial Fibrosis of Patients with Rheumatoid Arthritis

    by Na-Lin Lai, Wen Jia, Xia Wang, Jing Luo, Guang-Ying Liu, Chong Gao, Xiao-Feng Li, Jian-Fang Xie

    Objective. The absolute and relative changes of peripheral NK and T subsets are unclear in rheumatoid arthritis (RA) associated with pulmonary interstitial fibrosis (RA-ILD). To investigate the clinical risk factors, especially the changes of lymphocyte subsets, in RA-ILD in order to make early diagnosis and achieve prevention of the pulmonary interstitial lesions. Methods. A total of 100 RA and 100 RA-ILD patients were enrolled. Rheumatoid factor, anti-cyclic citrulline peptide antibody, erythrocyte sedimentation rate, immunoglobulin, and C-reactive protein were examined. The percentage and absolute number of NK, T, B, Treg, Th1, Th2, and Th17 cells in peripheral blood were determined by flow cytometry. Results. RA-ILD is more common in older and male RA patients and/or those with higher autoantibody titers. Flow cytometry showed that the absolute and relative numbers of CD56+ NK cells were significantly higher in RA-ILD (280.40 ± 180.51 cells/μl vs. 207.66 ± 148.57 cells/μl; 16.62 ± 8.56% vs. 12.11 ± 6.47%), whereas the proportion of T cells and CD4+ T cells was lower in peripheral blood of RA-ILD patients (69.82 ± 9.30%; 39.44 ± 9.87 cells/μl) than that in RA patients (74.45 ± 8.72%; 43.29 ± 9.10 cells/μl). Conclusions. The occurrence of RA-ILD is closely related to the older male patients with high titer of various self-antibodies. Imbalance of CD3−CD56+ NK cells and T cells with other subsets were found in RA-ILD patients, which, together with older age, male, and high levels of autoantibodies should be considered as risk factors of pulmonary interstitial lesions.


  • Open Access

    The Proportion of Regulatory T Cells in Patients with Ankylosing Spondylitis: A Meta-Analysis

    by Na-Lin Lai, Sheng-Xiao Zhang, Jia Wang, Jia-Qian Zhang, Cai-Hong Wang, Chong Gao, Xiao-Feng Li

    Objective.Accumulating evidence indicates that regulatory T cells (Tregs) may be involved in the pathogenesis of ankylosing spondylitis (AS). As different markers have been used to identify Tregs, some studies on the proportions of Tregs in AS patients have generated considerable controversy. To clarify the status of Tregs in such patients, we determine the proportion changes of peripheral Tregs during development of the disease, with different cellular markers.Methods. We systematically searched Embase, PubMed, Cochrane, Web of Knowledge, FDA.gov, and Clinical Trials.gov for the studies reporting the proportion of Tregs in AS patients. Using the PRISMA guidelines, we performed a random-effects meta-analysis of the frequencies of peripheral Tregs defined in different ways. Inconsistency was evaluated using theI-squared index (I2), and publication bias was assessed by examining funnel plot asymmetry using the Begger and Egger tests.Results.A total 29 studies involving 1732 participants were included in the meta-analysis. Their conclusions of using the diversity of Tregs surface markers were inconsistent with each other. No significant difference in the proportions of Tregs was evident regardless of the definitions used [−0.709, (−1.455, 0.037,p=0.063),I2=97.3%]. Six studies used “single CD25-positive” cells as Tregs, which revealed a significant increase in AS patients compared with healthy blood donors [0.736, (0.138, 1.334),p=0.016,I2=80.7%]. Notably, the proportions of “CD4+CD25+FOXP3+,” “CD4+CD25highCD127low/−,” or “CD4+CD25+CD127low” T cells were lower in AS patients [−2.856, (−4.645, −1.066),p=0.002; −1.812, (−2.648, −0.977),p<0.001; −1.12, (−1.605, −0.635),p<0.001]. Tregs defined as “CD25high,” “CD25bright,” “CD25bright/highCD127low/−,” “CD4+FOXP3+,” “CD4+CD25highFOXP3+,” and “CD4+CD25+CD127−” did not differ in proportion between AS patients and healthy blood donors.Conclusions.The levels of Tregs varied based on the cellular identification markers used. The proportions of CD4+CD25+FOXP3+Tregs, CD4+CD25highCD127low/−, or CD4+CD25+CD127lowin blood of AS patients were significantly decreased as compared with those in healthy blood donors, and our findings lend support to the idea that the Treg status of AS patients is important. And we recommend the above as the best definition of Tregs when evaluating the status of such patients.